Sara Tolaney, MD, MPH

Dana-Farber Cancer Institute

Latest Videos

Dr. Sara Tolaney, Dr. Rahul Gosain, and Dr. Rohit Gosain discuss new indications for Sacituzumab Govitecan in TNBC.

Breast Cancer

07/13/2026

ASCENT-03 and ASCENT-04 Lead to New Indications for Sacituzumab Govitecan in TNBC

Sara Tolaney, MD, MPHRahul Gosain, MD, MBARohit Gosain, MD

Enhanced breast cancer research presentation featuring Dr. Sara Tolaney, Dr. Rahul Gosain, and Dr. Rohit Gosain discussing T-DXd Plus Pertuzumab and new data in HER2+ metastatic breast cancer.

Breast Cancer

02/18/2026

T-DXd Plus Pertuzumab and New Data in HER2+ Metastatic Breast Cancer

Sara Tolaney, MD, MPHRohit Gosain, MDRahul Gosain, MD, MBA

An informative graphic featuring Dr. Sara Tolaney, Dr. Adam Brufsky, Dr. Rahul Gosain, and Dr. Rohit Gosain discussing the use of CDK4/6 inhibitors in HR+ breast cancer cases.

Breast Cancer

11/24/2025

Assessing CDK4/6 Inhibitor Use in HR+ Breast Cancer Cases

Sara Tolaney, MD, MPHAdam Brufsky, MD, PhDRohit Gosain, MDRahul Gosain, MD, MBA